Spectrila
Active substance: Asparaginase
asparaginase
Centralised EU authorisationActive
Marketing holder: Medac Gesellschaft fuer klinische Spezialpraeparate mbH
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
| US 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3045-7960-b407-0f6fe5d9d88c,01a120c3-677e-7de3-a722-297a4e3d6d52,01a120c3-695c-7bd5-891c-90e1e64616db,01a120c4-d190-7879-b6e3-7389c1e3e3a0,01a120c5-009f-703e-9d54-e198951c356c;count=6 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a12094-7953-75b3-8518-a7270b8f8aa6;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/002661
- Registration status
- Active
- ATC code
- L01XX02
Sources
- product · EMA · EMEA/H/C/002661 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002661 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002661 · Verified 2026-10-09